Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Kasper K Berthelsen"'
Autor:
David C.W. Lau, Domenica Rubino, Kasper K Berthelsen, Michael T. Lund, Martin Kankam, Altynai Satylganova, Lone B Enebo
Publikováno v:
The Lancet. 397:1736-1748
Summary Background Cagrilintide, a long-acting amylin analogue, and semaglutide 2·4 mg, a glucagon-like peptide-1 analogue, are both being investigated as options for weight management. We aimed to determine the safety, tolerability, pharmacokinetic
Autor:
Lone B Enebo, Martin Kankam, David C.W. Lau, Michael T. Lund, Kasper K Berthelsen, Domenica Rubino, Altynai Satylganova
Publikováno v:
Journal of the Endocrine Society
Background: Combining weight management medications with different modes of action may provide more effective treatment options for people with obesity. Subcutaneous (sc) AM833, a long-acting amylin analog, and sc semaglutide 2.4 mg, a glucagon-like
Autor:
Berthelsen, Kasper K., Møller, Jesper
Publikováno v:
Bulletin of the Brazilian Mathematical Society. Nov2002, Vol. 33 Issue 3, p351. 17p.
Publikováno v:
Review of Economics & Statistics. Mar2022, Vol. 104 Issue 2, p355-367. 13p. 1 Diagram, 5 Charts, 2 Graphs.
Autor:
Murawaki, Yugo1
Publikováno v:
Computational Linguistics. Jun2019, Vol. 45 Issue 2, p199-228. 30p.
Publikováno v:
Journal of the Endocrine Society; 2021 Supplement, Vol. 5, pA1-A1042, 1042p
Publikováno v:
Australian & New Zealand Journal of Statistics. Dec2007, Vol. 49 Issue 4, p457-457. 1p.
Autor:
Berthelsen, Kasper K.1 kkb@math.aau.dk, Møller, Jesper1
Publikováno v:
Australian & New Zealand Journal of Statistics. Sep2008, Vol. 50 Issue 3, p257-272. 16p. 6 Graphs.
Publikováno v:
Scandinavian Journal of Statistics. Sep2003, Vol. 30 Issue 3, p1. 1p.
Autor:
Berthelsen, Kasper K.1, Møller, Jesper1
Publikováno v:
Scandinavian Journal of Statistics. Sep2003, Vol. 30 Issue 3, p549-564. 16p.